Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors
| Autor: | Schaedler, Emmanuelle, Remy-Ziller, Christelle, Hortelano, Julie, Kehrer, Nadine, Claudepierre, Marie-Christine, Gatard, Tanja, Jakobs, Christopher, Préville, Xavier, Carpentier, Antoine F., Rittner, Karola |
|---|---|
| Zdroj: | In Vaccine 23 January 2017 35(4):577-585 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect